The AMD-associated CFH(Y402H) variant has been shown to provide toxic gain-of-function over wildtype CFH by increasing the persistence of MPs in the subretinal space through stronger binding to CD11b, which in turn obstructs TSP-1 binding to CD47 within the same lipid rafts [98]. This evidence concerns the gene CFH and age-related macular degeneration.